Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 64769

http://www.cdc.gov/ncipc/osp/

sharing_policy.htm

VI.3. Reporting 

You must provide CDC with an 

original, plus two hard copies of the 

following reports: 

1. Interim progress report, (use form 

PHS 2590, OMB Number 0925–0001, 

rev. 5/2001 as posted on the CDC 

website) no less than 90 days before the 

end of the budget period. The progress 

report will serve as your non-competing 

continuation application, and must 

contain the following elements:

a. Current budget period activities 

objectives. 

b. Current budget period financial 

progress. 

c. New budget period program 

proposed activity objectives. 

d. Budget. 

e. Measures of effectiveness. 

f. Additional requested information. 

2. Financial status report, no more 

than 90 days after the end of the budget 

period. 

3. Final financial and performance 

reports, no more than 90 days after the 

end of the project period. 

These reports must be mailed to the 

Grants Management Specialist listed in 

the ‘‘Agency Contacts’’ section of this 

announcement. 

VII. Agency Contacts 

We encourage inquiries concerning 

this announcement. 

For general questions, contact: 

Technical Information Management 

Section, CDC Procurement and Grants 

Office, 2920 Brandywine Road, Atlanta, 

GA 30341, Telephone: 770–488–2700. 

For scientific/research issues, contact: 

Karin Mack, Ph.D., National Center for 

Injury Prevention and Control, Centers 

for Disease Control and Prevention 

(CDC), 4770 Buford Hwy NE., Mailstop 

K–63, Atlanta, GA 30341. Telephone: 

770–488–4389. E-mail: KMack@cdc.gov.

For questions about peer review, 

contact: Gwendolyn Cattledge, PhD, 

Scientific Review Administrator, 

Associate Director for Extramural 

Research,National Center for Injury 

Prevention and Control Centers for 

Disease Control and Prevention (CDC), 

4770 Buford Highway, NE., Mailstop K–

02. Telephone: 770–488–1430. E-mail: 

gxc8@cdc.gov.

For financial, grants management, or 

budget assistance, contact: James 

Masone, Grants Management Specialist, 

CDC Procurement and Grants 

Office,2920 Brandywine Road, Atlanta, 

GA 30341. E-mail: JMasone@cdc.gov.

VIII. Other Information 

This and other CDC funding 

opportunity announcements can be 

found on the CDC web site, Internet 

address: www.cdc.gov. Click on 

‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements.’’

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–24715 Filed 11–5–04; 8:45 am] 

BILLING CODE 4163–18–U

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Public Health Injury Surveillance and 

Prevention Program 

Announcement Type: New. 

Funding Opportunity Number: CE05–

027. 

Catalog of Federal Domestic 

Assistance Number: 93.136. 

Key Dates: Letter of Intent Deadline: 

December 8, 2004. 

Application Deadline: February 7, 

2005. 

I. Funding Opportunity Description 

Authority: This program is authorized 

under sections 391(a) and 301(a) of the 

Public Health Service Act (PHS Act) and 

[42 U.S.C. 241(a) and 280b(a)], as 

amended. 

Purpose: The Centers for Disease 

Control and Prevention (CDC) 

announces the availability of fiscal year 

(FY) 2005 funds for a cooperative 

agreement program for the development, 

enhancement, and integration of injury 

prevention and control and surveillance 

programs. The purpose of this program 

is to enable State public health agencies 

to develop or strengthen their 

organizational focus related to the 

prevention and control of injuries and to 

develop or strengthen their injury 

surveillance programs, particularly 

those with a focus on traumatic brain 

injury (TBI). This program addresses the 

‘‘Healthy People 2010’’ focus area of 

Injury and Violence Prevention. 

This announcement incorporates 

funding guidance for the following four 

components: Part A—the Integrated 

Core Injury Prevention and Control 

(ICIPC) Program, Part B—the Traumatic 

Brain Injury Extended Surveillance 

(TBIES) Program, Part C—the Traumatic 

Brain Injury Emergency Department 

(TBIED) Surveillance Program and Part 

D—the Traumatic Brain Injury Service 

Linkage (TBISL) Program. All States/

territories must qualify and be 

recommended for funding for Part A 

(ICIPC) in order to be eligible for Part B 

(TBIES), Part C (TBIED) or Part D 

(TBISL). The ICIPC component supports 

the planning, implementation and 

integration of comprehensive injury 

prevention and control activities with 

basic injury surveillance activities. CDC 

defines injury program integration as a 

coordinated approach to reducing the 

incidence, morbidity and mortality of 

injury through surveillance and 

prevention efforts. The TBIES 

component supports efforts to provide 

expanded information on the incidence 

of traumatic brain injury. The TBIED 

component supports efforts to provide 

information on the incidence of mild 

traumatic brain injury treated in the 

emergency department. The TBISL 

component supports efforts to link 

individuals with traumatic brain injury 

to information about services. 

Measurable outcomes of the program 

will be in alignment with one (or more) 

of the following performance goal(s) for 

the National Center for Injury 

Prevention and Control: 

1. Increase the capacity of injury 

prevention and control programs to 

address the prevention of injuries and 

violence. 

2. Monitor and detect fatal and nonfatal injuries. 

This announcement is only for nonresearch activities supported by CDC/

ATSDR. If research is proposed, the 

application will not be reviewed. For 

the definition of research, please see the 

CDC Web site at the following Internet 

address: http://www.cdc.gov/od/ads/

opspoll1.htm

Activities 

Part A: The Integrated Core Injury 

Prevention and Control (ICIPC) Program 

In conducting activities to achieve the 

purpose of Part A of this program, the 

recipient will be responsible for 

incorporating the core components of a 

model State injury prevention program 

as outlined in the STIPDA: Safe States—

2003 Edition. For a downloadable 

version of this document, please see the 

STIPDA Web site at the following 

Internet address: http://www.stipda.org/

safestates.htm.Activities to be followed 

related to this requirement are described 

below. CDC has developed performance 

measures to evaluate recipients’

progress in meeting ICIPC requirements. 

These performance measures are listed 

following each associated recipient 

activity. Activities are as follows:

• Building a Solid Infrastructure for 

Injury Prevention and Control. 

Æ Enhance comprehensive injury 

prevention and control 

infrastructure by acquiring key staff 

and associated resources to

64770 Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 

coordinate and integrate 

comprehensive injury prevention 

and control efforts with statewide 

injury surveillance efforts. 

Performance will be measured by 

the extent to which the program 

has:

› Established the infrastructure for 

ICIPC including staff and other 

resources. 

› Where appropriate, established 

written inter-agency/organizational 

agreements (e.g. Memoranda of 

Understanding) related to the roles, 

duties and responsibilities of shared 

staff. 

Æ Mobilize support and build 

partnerships by identifying, 

contacting and inviting potential 

key private, professional, voluntary 

and nonprofit injury prevention and 

control organizations, injury care 

providers, policymakers, 

consumers, payers, media, State 

and Federal agencies, surveillance, 

research and academic institutions, 

and others to become members of a 

new or existing State/territory-wide 

Injury Community Planning Group 

(ICPG). The role of the ICPG may 

include, but should not be limited 

to: Participation of members on 

injury prevention and control 

boards and commissions, providing 

information on the effectiveness of 

existing State policies related to 

injury prevention and control, and 

reviewing surveillance data to help 

identify and prioritize injury 

problems within the State. 

Performance will be measured by 

the extent to which the program 

and ICPG has developed and sought 

guidance from coalitions and 

partners, both within and outside of 

the organization and sustained 

these partnerships as ongoing 

entities by such activities as: 

› Generating support and resources 

or securing funding to support 

Integrated Core Injury Prevention 

and Control Program (ICIPC) 

activities. 

› Establishing written 

responsibilities for the ICPG (e.g., in 

a mission statement or scope of 

work). 

› Supporting the ICPG process by 

providing funding and resources. 

› Assuring the ICPG has access to 

current information about injury 

prevention and control. 

› Conducting one ICPG injury 

prevention symposium per budget 

year to develop specific marketing 

injury strategies for the 

comprehensive injury prevention 

plan. The symposium should 

include, but not be limited to: 

Regional/statewide representatives 

of key governmental and nongovernmental agencies; media 

outlets; HMOs/MCOs; hospital/

trauma/medical centers; state 

athletic associations; medical/

professional organizations/

associations and other stakeholders 

or gatekeepers. 

Æ Develop a State injury prevention 

and control plan, or where 

appropriate, conduct a systematic 

evaluation and update of the 

existing injury prevention and 

control plan. In each case, the 

recipient should work with their 

ICPG to assure that their plan 

includes prioritized measurable 

goals and objectives with 

timeframes, and identifies 

implementing organizations for 

priority plan strategies. 

Performance will be measured by 

the extent to which the plan reflects 

that the program: 

› Used data to describe the 

epidemiology of the burden of 

injury in the State/territory. 

› Evaluated the epidemiologic data 

to determine the critical target areas 

for injury prevention and control 

activities. 

› Established priorities and chosen 

appropriate evidence-based 

intervention strategies. 

› Identified implementing 

organizations for priority plan 

strategies. 

› Developed objective/quantitative 

measures of effectiveness that will 

demonstrate accomplishment of 

program goals and objectives and 

measure intended outcomes. 

Æ Collaborate and coordinate with 

your State’s Office of Terrorism 

Preparedness and Emergency 

Response (or its equivalent) to 

assure their participation in the 

ICPG and in the development/

update of the State injury 

prevention and control plan. 

Performance will be measured by 

the extent to which the program 

secures memorandums of 

understanding (MOU) documenting 

this collaboration. 

• Collect, Analyze and Use Injury Data 

Æ States/Territories must collect and 

analyze injury data including, but 

not limited to, data related to: 

Traumatic brain injuries (TBI) and 

the following external causes: 

drowning, fire-related injuries, 

motor vehicle injuries, poisonings, 

firearm-related injuries, homicides, 

suicides, and those injuries 

resulting from mass casualty events 

for their own use from centralized 

electronic hospital discharge data 

and centralized electronic vital 

statistics data sets [see eligibility 

information (i.e., Special 

Requirements) for allowable 

exceptions]. Performance will be 

measured based upon the extent to 

which the program has 

demonstrated that it: 

› Used available data to inform the 

injury prevention and control 

planning process. 

› Used available data to evaluate 

progress toward meeting the core 

goals and objectives of the state/

territory injury prevention and 

control program. 

› Promoted and facilitated the use of 

injury data to meet the needs of 

injury prevention and control 

groups and service agencies (e.g.,

HRSA).

› Participated in the Multi-State 

Injury Indicator Report. 

Æ States/Territories must submit an 

annual injury data report produced 

for use in their own state/territory 

and for submission to CDC. This 

report shall be consistent with 

CDC’s current recommendations for 

Injury Indicator Surveillance (see

Appendix 1 for detailed 

methodology). In addition, this 

report shall include completed 

tables with aggregated numbers and 

rates categorized by sex, age group, 

and external cause for All-injury 

deaths and hospitalizations, TBI 

related deaths and hospitalizations, 

drowning related deaths and 

hospitalizations, fire related deaths 

and hospitalizations, motor vehicle 

related deaths and hospitalizations, 

poisoning related deaths and 

hospitalizations, firearm related 

deaths and hospitalizations, suicide 

related deaths and hospitalizations, 

and homicides. The report shall 

include a written interpretation of 

the injury data in a format suitable 

for dissemination within the State/

territory and shall include a focus 

on priority areas identified by the 

State/territory and a brief analysis 

of TBI in the state/territory. 

Performance will be measured by 

the extent to which the program 

has: 

› Incorporated CDC’s 

recommendations for data 

completeness, timeliness, and 

quality. 

› Compliance will be determined 

based upon the successful 

submission of required annual 

reports and the completeness of the 

submitted spreadsheet tables 

(spreadsheet format will be 

supplied by CDC). 

› The first annual injury data report

Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 64771

should include data from 01/01/

2004–12/31/2004. The report must 

be received as an attachment to the 

annual report (due October 31). For 

example, CDC should receive the 

first report using 2004 data no later 

than October 31, 2006. Subsequent 

annual reports will follow the same 

pattern. 

• Implement, and Evaluate 

Interventions 

Æ Implement priorities as established 

by the State/territory 

comprehensive injury prevention 

and control plan, which provides a 

framework for action to reduce the 

burden of injury in the State/

territory. Performance will be 

measured by the extent to which 

the program has: 

› Identified interventions focused on 

priorities outlined in the state/

territory wide injury prevention and 

control plan. 

› Identified and collaborated with 

influential and appropriate partners 

who are able to implement and 

support injury prevention and 

control plan activities/strategies. 

› Continuously evaluated and 

monitored its own process and the 

outcomes of the ICIPC plan, its 

objectives and activities. 

Æ Use surveillance findings to inform 

and guide State/territory injury 

prevention and control activities, 

including the ICIPC where 

applicable. Performance will be 

measured by the extent to which 

the program has: 

› Used surveillance findings to 

guide injury prevention and control 

activities. 

› Used surveillance findings to 

evaluate the effectiveness of 

intervention programs. 

• States/Territories funded under this 

cooperative agreement must send 

representation to the annual CDC 

sponsored grantees meeting. 

Part B: Traumatic Brain Injury Extended 

Surveillance (TBIES) Program 

In conducting activities to achieve the 

purpose of Part B of this program, the 

recipients will be responsible for 

conducting all of the activities of Part A 

as well as the activities described below. 

CDC has developed performance 

measures to evaluate recipients’

progress in meeting TBIES 

requirements. These performance 

measures are listed following each 

associated recipient activity. Activities 

are as follows: 

› TBI Basic Electronic Surveillance 

Æ Conduct centralized statewide 

electronic surveillance of TBI, 

consistent with standard definitions 

and methods for TBI surveillance 

described in the current Annual 

Data Submission Standards for 

Central Nervous System (CNS) 

Injury Surveillance. For a 

downloadable version of this 

document, please see the CDC Web 

site at the following Internet 

address: http://www.cdc.gov/

doc.do/id/

0900f3ec80145eec.Performance will 

be measured by the extent to which 

the program has:

› Used centralized statewide 

electronic hospital discharge and 

vital statistics databases for case 

identification. 

› Linked and unduplicated data 

obtained from centralized statewide 

electronic hospital discharge and 

vital statistics databases, including 

data elements that describe 

diagnosis, demographics, external 

cause, and discharge disposition. 

• TBI Extended Medical Record 

Surveillance 

Æ Annually review the medical 

records of a representative sample 

of reported hospitalized cases to 

obtain data consistent with 

standard definitions for the 

expanded TBI dataset described in 

the current Central Nervous System 

Injury Surveillance Data 

Submission Standards. Performance 

will be measured by the extent to 

which the program has: 

› Complied with CDC’s standards 

for data completeness and quality. 

Compliance will be determined 

based on an evaluation of data 

submitted to CDC’s National Center 

for Injury Prevention and Control. 

The first annual data submission 

should include data from 01/01/

2004–12/31/2004. The data must be 

received by CDC as an attachment 

to the annual report. For example, 

CDC should receive the first data 

submission using 2004 data no later 

than October 31, 2006. Subsequent 

annual data submissions will follow 

the same pattern. 

Æ During years two through five 

collect additional information on 

10–15 TBI data elements related to 

a topic of emerging public health 

importance. CDC and all grantees 

participating in extended 

surveillance will jointly decide 

upon topic areas during year 1. 

Performance will be measured by 

the extent to which the program 

has: 

› Complied with data collection 

efforts mutually agreed upon by 

CDC and the program. Compliance 

will be determined based on an 

evaluation of data submitted to 

CDC’s National Center for Injury 

Prevention and Control. 

• Analysis and Reporting 

Æ Analyze and interpret collected 

data and prepare an annual report 

suitable for dissemination within 

the State/territory either separately 

or within the All-injury report 

described in Part A. Performance 

will be measured by the extent to 

which the program: 

› Successfully disseminates the 

report within the State/territory and 

submits the report to CDC’s NCIPC. 

Æ Generate an annual summary report 

documenting methodological and 

other issues related to conducting 

extended surveillance to include 

programmatic lessons learned, 

strengths and limitations of the 

data, usefulness of the data for 

State/territory injury prevention 

and control planning, etc. This 

information will be used to expand 

and improve the content of CDC’s 

‘‘Annual Data Submission 

Standards, Central Nervous System 

Injury Surveillance.’’ Performance 

will be measured by the extent to 

which the program: 

› Successfully submits the report to 

CDC’s National Center for Injury 

Prevention and Control. 

Part C: Traumatic Brain Injury 

Emergency Department Surveillance 

(TBIED) Program 

In conducting activities to achieve the 

purpose of Part C of this program, the 

recipients will be responsible for 

conducting all the activities of Part A as 

well as the activities described below. 

CDC has developed performance 

measures to evaluate recipients’

progress in meeting TBIED 

requirements. These performance 

measures are listed following each 

associated recipient activity. Activities 

are as follows: 

• Basic Electronic Surveillance 

Æ Conduct centralized statewide 

electronic emergency department 

(ED) surveillance of TBI, consistent 

with standard definitions and 

methods for TBI surveillance 

described in the current Central 

Nervous System Injury Surveillance 

Data Submission Standards. 

Performance will be measured by 

the extent to which the program 

has: 

› Used centralized statewide 

electronic ED databases for case 

identification. 

› Linked and unduplicated data 

obtained from centralized statewide 

electronic ED databases with 

centralized electronic hospital 

discharge data and centralized

64772 Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 

electronic vital statistics data. 

• Emergency Department Surveillance 

Æ Annually review the medical 

records of a representative sample 

of reported cases to obtain data 

consistent with standard definitions 

for the extended TBI dataset 

described in the current Central 

Nervous System Injury Surveillance 

Data Submission Standards. In 

addition to the evaluation measures 

included in the current Central 

Nervous System Injury Surveillance 

Data Submission Standards, 

perform an annual evaluation of 

sensitivity to include at a minimum 

a qualitative assessment of the data 

sources (e.g., number and 

proportion of EDs participating in 

the State). Performance will be 

measured by the extent to which 

the program has: 

› Complied with CDC’s standards 

for data completeness and quality. 

Compliance will be determined 

based on an evaluation of data 

submitted to CDC’s National Center 

for Injury Prevention and Control. 

The first annual data submission 

should include data from 01/01/

2004–12/31/2004. The data must be 

received by CDC as an attachment 

to the annual report. For example, 

CDC should receive the first data 

submission using 2004 data no later 

than October 31, 2006. Subsequent 

annual data submissions will follow 

the same pattern. 

• Analysis and Reporting 

Æ Analyze and interpret collected 

data and prepare an annual report 

suitable for dissemination within 

the State/territory either separately 

or within the All-injury report 

described in Part A. Performance 

will be measured by the extent to 

which the program: 

› Successfully disseminates the 

report within the State/territory and 

submits the report to CDC’s 

National Center for Injury 

Prevention and Control. 

Æ Generate an annual summary report 

documenting methodological and 

other issues related to conducting 

ED surveillance to include 

programmatic lessons learned, 

strengths and limitations of the 

data, usefulness of the data for 

State/territory injury prevention 

and control planning, etc. This 

information will be used to expand 

and improve the content of CDC’s 

‘‘Guidelines for ED Surveillance.’’

Performance will be measured by 

the extent to which the program:

› Successfully submits the report to 

CDC’s National Center for Injury 

Prevention and Control. 

Part D: Traumatic Brain Injury Service 

Linkage (TBISL) Program 

In conducting activities to achieve the 

purpose of Part D of this program, the 

recipients will be responsible for 

conducting all of the activities of Part A 

as well as the activities described below. 

CDC has developed performance 

measures to evaluate recipients’

progress in meeting TBISL 

requirements. These performance 

measures are listed following associated 

recipient activities. Activities are as 

follows: 

• Feasibility assessment 

Æ In year one, conduct an assessment 

of the feasibility of (a) obtaining 

from the State/territory TBI 

surveillance system, personal 

identifying and contact information 

for a sample of persons hospitalized 

with TBI and (b) using that 

information to provide those 

individuals with information about 

available services in their State. 

Performance will be measured by 

the extent to which the program: 

› Submits a report summarizing the 

results of the feasibility assessment. 

This assessment should identify 

potential partners for linkage 

activities and discuss the pros and 

cons of differing linkage strategies 

within the State/territory. 

Information to be collected will be 

decided upon in collaboration with 

CDC. The feasibility assessment 

report must be submitted as an 

attachment to the Year one interim 

report (due six months after the 

beginning of the budget period). 

Æ In year one, develop and submit a 

plan for linkage implementation 

based on results of the feasibility 

study. The plan for linkage 

implementation must be submitted 

as part of the Year one annual 

report due October 31, 2006. 

Performance will be measured by 

the extent to which the plan: 

› Describes the populations to be 

linked, including justification for 

their selection. 

› Clearly describes the methods for 

proposed linkage activities 

including a process for identifying 

and linking persons to information 

about services within an 

appropriate timeframe post injury. 

› Identifies partners with whom 

they will collaborate in conducting 

linkage activities and from whom 

they have received letters of 

support. 

• Implementation 

Æ In year two, States must implement 

proposed linkage activity(ies) as a 

pilot and prepare a report, which 

includes findings/results and 

lessons learned. The report must be 

submitted as an attachment to the 

Year two annual report due October 

31, 2007. Performance will be 

measured by the extent to which 

the program: 

› Has successfully implemented 

pilot activities and has summarized 

their actions in a report to the 

CDC’s National Center for Injury 

Prevention and Control. 

Æ In years three through five, States/

territories must conduct the linkage 

activity(ies), and prepare an annual 

report summarizing the activity 

including; findings/results, lessons 

learned, and implications/

recommendations for future 

activities in this and in other States/

territories. The report must be 

submitted as an attachment to the 

Year three to five annual reports, 

due October 31st. Performance will 

be measured by the extent to which 

the program has: 

› Continuously evaluated and 

monitored its own process, 

objectives and activities. 

› Developed and monitored 

measures of effectiveness for its 

proposed activities. 

› Successfully submitted required 

reports. 

In a cooperative agreement, the staff 

of CDC staff is substantially involved in 

the program activities, above and 

beyond routine grant monitoring. 

CDC Activities for this program are as 

follows: 

Part A 

• Assist with the exchange of 

information and collaboration among 

recipients. 

• Provide recipients with relevant 

research findings and public health 

recommendations related to 

comprehensive injury prevention and 

control. 

• Provide ongoing guidance, 

consultation, and technical assistance in 

conducting recipient activities. 

• Assist with the identification of 

national injury prevention and control 

campaigns and materials that can be 

integrated into comprehensive injury 

prevention and control programs. 

• Provide recipients with instructions 

and spreadsheets for calculating annual 

injury indicator data. 

Part B 

• Provide ongoing guidance, 

consultation, and technical assistance in 

conducting recipient activities. 

• Collaborate with grantees to 

establish standards for data 

completeness, timeliness, and quality,

Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 64773

and to promote the use of TBI data to 

support injury prevention and control 

efforts. 

• Receive, assess, aggregate and 

disseminate TBI data from grantees. 

Part C 

• Provide ongoing guidance, 

consultation, and technical assistance in 

conducting recipient activities. 

• Collaborate with grantees to 

establish standards for data 

completeness, timeliness, and quality, 

and to promote the use of TBI data to 

support injury prevention and control 

efforts. 

• Receive, assess, aggregate and 

disseminate TBI data from grantees. 

Part D 

• Assist with the exchange of 

information and collaboration among 

recipients.

• Provide ongoing guidance, 

consultation, and technical assistance in 

conducting recipient activities. 

II. Award Information 

Type of Award: Cooperative 

Agreement. 

Budgets should be prepared for Parts 

A, B, C, & D separately. In the 

application packet, you should list each 

Part’s budget amount in separate 

columns on the SF424 (i.e., Part A in 

column 1, Part B in column 2, Part C in 

column 3 and Part D in column 4). 

Details on this form and instructions for 

submitting an application are provided 

in the ‘‘Application and Submission’’

section. CDC involvement in this 

program is listed in the Activities 

Section above. 

Part A (ICIPC) 

Fiscal Year Funds: 2005. 

Approximate Total Funding 

Available: $4,750,000. 

Approximate Number of Awards: 33. 

Approximate Funding per Award:

$144,000. 

Floor of Award Range: None. 

Ceiling of Award Range: $150,000. 

Part B (TBIES) 

Fiscal Year Funds: 2005. 

Approximate Total Funding 

Available: $440,000. 

Approximate Number of Awards:

Four. 

Approximate Funding per Award:

$110,000. 

Floor of Award Range: None. 

Ceiling of Award Range: $110,000. 

Part C (TBIED) 

Fiscal Year Funds: 2005. 

Approximate Total Funding 

Available: $300,000. 

Approximate Number of Awards:

Two. 

Approximate Funding per Award:

$150,000. 

Floor of Award Range: None. 

Ceiling of Award Range: $150,000. 

Part D (TBISL) 

Fiscal Year Funds: 2005. 

Approximate Total Funding 

Available: $150,000. 

Approximate Number of Awards:

Three. 

Approximate Funding per Award:

$50,000. 

Floor of Award Range: None. 

Ceiling of Award Range: $50,000. 

If you request a funding amount 

greater than the ceiling of award range 

per Part, your application will not be 

considered eligible and not forwarded 

for review. This ceiling of award range 

per part is for the first 12-month budget 

period and includes both indirect and 

direct costs. If considered ineligible, you 

will be notified in writing by NCIPC 

prior to start date of the award. 

Anticipated Award Start Date: August 

1, 2005. 

Budget Period Length: 12 months. 

Project Period Length: Five years. 

Throughout the project period, CDC’s 

commitment to continuation of awards 

will be conditioned on the availability 

of funds, evidence of satisfactory 

progress by the recipient (as 

documented in required reports), and 

the determination that continued 

funding is in the best interest of the 

Federal Government. 

III. Eligibility Information 

III.1. Eligible Applicants 

Applications may be submitted by 

health departments of States and 

territories or their bona fide agents, this 

includes the District of Columbia, the 

Commonwealth of Puerto Rico, the 

Virgin Islands, the Commonwealth of 

the Northern Mariana Islands, American 

Samoa, Guam, the Federated States of 

Micronesia, the Republic of the 

Marshall Islands, and the Republic of 

Palau. A Bona Fide Agent is an agency/

organization identified by the State/

territory as eligible to submit an 

application under the State/territory 

eligibility in lieu of a State/territory 

application. If you are applying as a 

bona fide agent of a State/territory, you 

must provide documentation of your 

status. Place this documentation behind 

the first page of your application form. 

Special Requirements: If your 

application is incomplete or nonresponsive to the requirements listed 

below, it will not be entered into the 

review process. You will be notified that 

your application did not meet the 

submission requirements. 

• All States/territories should 

demonstrate the ability to access a 

centralized electronic hospital discharge 

data set. States/Territories unable to 

access centralized electronic hospital 

discharge data sets must demonstrate 

the ability to access an alternate 

centralized electronic data set that is 

representative of the State/territory 

hospitals. As an appendix to this 

application include a summary of 

current (i.e., 2001, 2002 or most current 

morbidity data analyzed by age, sex and 

cause). 

• All States/territories must 

demonstrate the ability to access 

centralized electronic vital statistics 

data sets. As an appendix to this 

application include a summary of 

current (i.e., 2001, 2002 or most current 

mortality data analyzed by age, sex and 

cause). 

• States/territories previously funded 

under program announcement numbers 

00119, 02207 and 99136 must submit a 

State/territory-wide injury prevention 

and control plan as an appendix to this 

application. 

• States/Territories must maintain an 

active Injury Community Planning 

Group (ICPG) the ICPG shall be 

responsible for developing/enhancing 

injury prevention and control plan and 

marketing strategy to promote the vision 

and values of the Integrated Core Injury 

Prevention and Control Program. 

• All States/territories must qualify 

and be recommended for funding for 

Part A (ICIPC) in order to be eligible for 

Part B (TBIES), Part C (TBIED) or Part 

D (TBISL). Note: For this reason, the 

CDC review panel will only consider 

Parts B, C and D of the applications 

reviewed, approved and funded for Part 

A. 

• States/Territories applying for Part 

C (TBIED) must demonstrate the ability 

to access centralized electronic 

emergency department discharge data 

sets.

• States/Territories applying for Part 

D (TBISL) who propose direct patient 

contact must have legal authority to 

contact individuals identified by 

surveillance activities. In order to 

demonstrate legal authority applicants 

must submit both of the following as an 

appendix to the application: A copy of 

the supporting legislation/regulation 

and a letter from the appropriate health 

department official (e.g. attorney or 

health officer) certifying that the 

applicant will have access to personal 

identifying information of TBI cases for 

the purposes of the linkage activities 

outlined in this RFA.

64774 Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 

• Note: Title 2 of the United States 

Code Section 1611 states that an 

organization described in Section 

501(c)(4) of the Internal Revenue Code 

that engages in lobbying activities is not 

eligible to receive Federal funds 

constituting an award, grant, or loan. 

III.2. Cost Sharing or Matching 

Matching funds are not required for 

this program. 

IV. Application and Submission 

Information 

IV.1. Address To Request Application 

Package 

To apply for this funding opportunity 

use application form CDC 5161. 

Application forms and instructions are 

available on the CDC Web site, at the 

following Internet address: 

www.cdc.gov/od/pgo/forminfo.htm.

If you do not have access to the 

Internet, or if you have difficulty 

accessing the forms on-line, you may 

contact the CDC Procurement and 

Grants Office Technical Information 

Management Section (PGO–TIM) staff 

at: (770) 488–2700. Application forms 

can be mailed to you. 

IV.2. Content and Form of Submission 

Letter of Intent (LOI): CDC requests 

that you submit a LOI if you intend to 

apply for one or more parts of this 

program. Your LOI will be used to gauge 

the level of interest in this program, and 

to allow CDC to plan the application 

review. Your LOI must be written in the 

following format: 

• Maximum number of pages: Two. 

• Font size: 12-point unreduced. 

• Single spaced. 

• Paper size: 8.5 by 11 inches. 

• Page margin size: One inch. 

• Printed only on one side of page. 

• Written in plain language, avoid 

jargon. 

Your LOI must contain the following 

information: 

• Number and title of this Program 

Announcement (PA#). 

• Identification of Part(s) for which 

you intend to apply. 

Application: You are required to send 

a cover letter that summarizes which 

Parts you are applying for, dollar 

amounts, and point of contact 

information. Ensure that each part of the 

application and section are properly 

labeled and include page numbers. A 

detailed budget and narrative 

justification must be provided. 

Guidance for completing your budget 

can be found on the CDC Web site, at 

the following Internet address: http://

www.cdc.gov/od/pgo/funding/

budgetguide.htm.You must include a 

table of contents. You must submit a 

project narrative with your application 

forms. Your narrative must be submitted 

in the following format: 

• Maximum number of pages: Part 

A—25; Part B—15; Part C—15; Part D—

10. If your narrative exceeds the page 

limit, only the first pages, which are 

within the page limit, will be reviewed. 

• Font size: 12 point unreduced. 

• Double spaced. 

• Paper size: 8.5 by 11 inches. 

• Page margin size: One inch. 

• Printed only on one side of page. 

• Held together only by rubber bands 

or metal clips; not bound in any other 

way. 

Your narrative should address 

activities to be conducted over the 

entire project period, and must include 

the following items in the order listed: 

• Part A: Executive summary, state of 

need, goals and objectives, methods and 

staffing, evaluation, collaboration, and 

budget and justification (appendices, 

budget and justification will not be 

counted in the stated page limit). 

• Part B: Executive summary, review 

of literature and statement of need, 

methods and activities, capacity to 

conduct TBI Surveillance, goals and 

objectives, management and staffing, 

evaluation, and budget and justification 

(appendices, budget and justification 

will not be counted in the stated page 

limit).

• Part C: Executive summary, review 

of literature and statement of need, 

methods and activities, capacity to 

conduct TBI ED surveillance, goals and 

objectives, management and staffing, 

evaluation, and budget and justification 

(appendices, budget and justification 

will not be counted in the stated page 

limit). 

• Part D: Executive summary, review 

of literature and statement of need, 

methods and activities, capacity, goals 

and objectives, management and 

staffing, evaluation, collaboration and 

budget and justification (appendices, 

budget and justification will not be 

counted in the stated page limit). 

• Additional information may be 

included in the application appendices. 

The appendices will not be counted 

toward the narrative page limit. 

You are required to have a Dun and 

Bradstreet Data Universal Numbering 

System (DUNS) number to apply for a 

grant or cooperative agreement from the 

Federal government. The DUNS number 

is a nine-digit identification number, 

which uniquely identifies business 

entities. Obtaining a DUNS number is 

easy and there is no charge. To obtain 

a DUNS number, access 

www.dunandbradstreet.com or call 1–

866–705–5711. 

For more information, see the CDC 

Web site at: http://www.cdc.gov/od/pgo/

funding/pubcommt.htm. Additional 

requirements that may require you to 

submit additional documentation with 

your application are listed in section 

‘‘VI.2. Administrative and National 

Policy Requirements.’’

IV.3. Submission Dates and Times 

LOI Deadline Date: December 8, 2004. 

CDC requests that you send a LOI if 

you intend to apply for this program. 

Although the LOI is not required, not 

binding, and does not enter into the 

review of your subsequent application, 

the LOI will be used to gauge the level 

of interest in this program, and to allow 

CDC to plan the application review. 

Application Deadline Date: February 

7, 2005. 

Explanation of Deadlines:

Applications must be received in the 

CDC Procurement and Grants Office by 

4 p.m. eastern time on the deadline 

date. If you submit your application by 

the United States Postal Service or 

commercial delivery service, you must 

ensure that the carrier will be able to 

guarantee delivery by the closing date 

and time. If CDC receives your 

submission after closing due to: (1) 

Carrier error, when the carrier accepted 

the package with a guarantee for 

delivery by the closing date and time, or 

(2) significant weather delays or natural 

disasters, you will be given the 

opportunity to submit documentation of 

the carriers guarantee. If the 

documentation verifies a carrier 

problem, CDC will consider the 

submission as having been received by 

the deadline. 

This announcement is the definitive 

guide on LOI and application content, 

submission address, and deadline. It 

supersedes information provided in the 

application instructions. If your 

submission does not meet the deadline 

above, it will not be eligible for review, 

and will be discarded. You will be 

notified that you did not meet the 

submission requirements. 

CDC will not notify you upon receipt 

of your submission. If you have a 

question about the receipt of your LOI 

or application, first contact your courier. 

If you still have a question, contact the 

PGO–TIM staff at: (770) 488–2700. 

Before calling, please wait two to three 

days after the submission deadline. This 

will allow time for submissions to be 

processed and logged.

IV.4. Intergovernmental Review of 

Applications 

Your application is subject to 

Intergovernmental Review of Federal 

Programs, as governed by Executive

Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 64775

Order (EO) 12372. This order sets up a 

system for State and local governmental 

review of proposed Federal assistance 

applications. You should contact your 

State Single Point of Contact (SPOC) as 

early as possible to alert the SPOC to 

prospective applications, and to receive 

instructions on your State’s process. 

Click on the following link to get the 

current SPOC list: http://

www.whitehouse.gov/omb/grants/

spoc.html. 

IV.5. Funding Restrictions 

Restrictions, which must be taken into 

account while writing your budget, are 

as follows: 

• Funds may not be used for research. 

• Reimbursement of pre-award costs 

is not allowed. 

• Federal funds awarded under this 

announcement may not be used to offset 

existing, State funded projects. 

If you are requesting indirect costs in 

your budget, you must include a copy 

of your indirect cost rate agreement. If 

your indirect cost rate is a provisional 

rate, the agreement should be less than 

12 months of age 

IV.6. Other Submission Requirements 

LOI Submission Address: Submit your 

LOI by express mail, delivery service, 

fax, or e-mail to: Angela Marr, 4770 

Buford Hwy., NE., M.S. F–41, Atlanta, 

GA 30341–3724. Tel: (770) 488–

1428.Fax: (770) 488–4338. E-mail: 

amarr@cdc.gov. 

Application Submission Address:

Submit the original and two hard copies 

of your application by mail or express 

delivery service to:Technical 

Information Management—#CE05–027, 

CDC Procurement and Grants 

Office,2920 Brandywine Road,Atlanta, 

GA 30341. 

Applications may not be submitted 

electronically at this time. 

V. Application Review Information 

V.1. Criteria 

Applicants are required to provide 

measures of effectiveness that will 

demonstrate the accomplishment of the 

various identified objectives of the 

cooperative agreement. Measures of 

effectiveness must relate to the 

performance goals stated in the 

‘‘Purpose’’ section of this 

announcement. Measures must be 

objective and quantitative, and must 

measure the intended outcome. These 

measures of effectiveness must be 

submitted with the application and will 

be an element of evaluation. 

Your application will be evaluated 

against the following criteria: 

Part A (ICIPC) 

Each application will be evaluated 

and scored individually by an objective 

review panel. Evaluation and scoring for 

Part A will be conducted according to 

the following criteria: 

• Need for an Integrated Core Injury 

Prevention and Control Program (30 

points) 

Æ Did the applicant describe the need 

for an Integrated Core Injury 

Prevention and Control Program 

and the nature of any current injury 

prevention and control or 

surveillance programs in their 

State? 

Æ Did the applicant describe the 

current level of agency/inter-agency 

resources dedicated to injury 

activities and how additional 

funding will contribute to efforts to 

initiate or improve existing or 

planned injury surveillance 

activities? 

Æ Did the applicant provide evidence 

of a current or existing injury 

prevention and control plan to 

develop or enhance its injury 

prevention and control or 

surveillance system? 

• Methods and Staffing (30 points) 

Æ Did the applicant provide a 

detailed description of how staffing 

resources (including 

epidemiological resources) will be 

allocated and used to accomplish 

each objective and overall program 

goals? 

Æ Did the application include the 

designation of a coordinator with 

the responsibility for coordinating 

Integrated Core Injury Prevention 

and Control Program activities? 

Æ Did the applicant provide a 

reasonable and complete timeline 

for implementing and completing 

all activities and objectives? 

Æ Did the application provide a 

description of the roles of each unit, 

organization, or agency, as well as 

evidence of coordination, 

supervision, and degree of 

commitment (e.g., time, in-kind, 

financial) of staff, organizations, 

and agencies involved in Integrated 

Core Injury Prevention and Control 

Program activities? 

Æ Did the application provide 

evidence of access to or assignment 

of epidemiological expertise for 

performing routine data review and 

analysis activities and providing 

technical advice and consultation? 

Æ Did the applicant provide evidence 

of intra-agency memoranda of 

understanding outlining; roles, 

duties, responsibilities and travel 

authorization for shared staff where 

appropriate to travel to CDC 

sponsored meetings? 

• Evaluation (20 points)

Æ Is the proposed evaluation system 

detailed? Does it address the goals 

and objectives of the program? Will 

it effectively evaluate program 

progress, effectiveness, and impact? 

Æ Does the application demonstrate 

the availability of potential data 

sources for evaluation purposes? 

Does it outline methods to evaluate 

the data sources? Does it document 

the availability of staff with the 

appropriate expertise, experience 

and capacity to perform program 

evaluation? 

Æ Does the application present a 

feasible plan for reporting 

evaluation results and for using 

evaluation information for 

programmatic decisions and 

continuous program improvement? 

• Goals and Objectives (10 points) 

Æ Did the applicant include goals that 

are relevant to the purpose of the 

proposal and feasible to accomplish 

during the project period? Are the 

goals specific and measurable? 

Æ Did the applicant include objectives 

that are feasible to accomplish 

during the budget period? Are the 

activities outlined necessary to 

accomplish the purpose of the 

proposal? 

• Collaboration (10 points) 

Æ Has the applicant provided 

adequate information to assess the 

relationships between the program 

and other organizations, agencies, 

and health department units that 

will relate to the program or 

conduct related activities? 

Æ Has the applicant provided a clear 

and adequate description of 

appropriate membership and roles 

of an Injury Community Planning 

Group? 

Æ Did the applicant provide evidence 

of intra-agency memoranda of 

understanding outlining roles, 

duties, responsibilities and travel 

authorization where appropriate to 

travel to CDC sponsored meetings? 

• Budget and Justification (not scored) 

Æ Has the applicant provided a 

detailed budget and narrative 

justification consistent with the 

stated objectives and planned 

program activities? 

Æ Has the applicant provided a budget 

to include funds for attending the 

annual grantees meeting? 

Part B (TBIES) 

Each application will be evaluated 

and scored individually by an objective 

review panel. All applications will be 

evaluated and scored first for Part A and

64776 Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 

subsequently, where applicable, for Part 

B. 

Evaluations and scoring for Part B 

will be conducted according to the 

following criteria:

• Methods and Activities: (35 points) 

Æ Can the methods and activities 

achieve the proposed objectives, 

consistent with the purposes of this 

announcement? Did the applicant 

propose appropriate methods and 

activities to collect and analyze 

optional data consistent with the 

Program Requirements for Part B, 

including sampling methods and 

proposed staffing? 

• Capacity to conduct TBI 

surveillance: (20 points) 

Æ Did the applicant demonstrate 

authority to collect and maintain 

necessary TBI surveillance data 

consistent with the current CDC 

Central Nervous System Injury 

Surveillance Data Submission 

Standards, with demonstrated 

timeliness of case ascertainment, 

completeness of case ascertainment, 

and ability to analyze data? Did the 

applicant demonstrate appropriate 

existing capacity to collect and 

analyze optional data (e.g., 

describing TBI severity, 

circumstances, and early outcome) 

from a representative sample of 

cases reported to the TBI 

surveillance system? If previously 

funded under PA #01030, did the 

applicant provide evidence of 

successful TBI surveillance 

activities, including: 

› A summary of current (i.e., 2001, 

2002 or most current) TBI morbidity 

and mortality data analyzed by age, 

sex, and cause; 

› An evaluation of TBI surveillance 

data quality (e.g., predictive value 

positive, completeness, timeliness); 

› Letter(s) from CDC indicating 

successful submission of annual 

datasets for 2000, 2001 and 2002?

If not previously funded under 

PA#01030, did the applicant provide 

evidence of successful TBI surveillance 

capacity, including:

› A summary of current (i.e., 2001, 

2002, or most current) TBI 

morbidity and mortality data 

analyzed by age, sex, and cause; 

› An evaluation of TBI surveillance 

data quality (e.g., predictive value 

positive, completeness, timeliness).

• Management and Staffing: (20 points) 

» Does the staffing plan indicate the 

applicant’s ability to carry out the 

objectives of the program? 

Considerations include: 

organizational structure, staff 

qualifications, experience, degree of 

stability maintaining current staff in 

critical positions, identified training 

needs or plan, and job descriptions 

and curricula vitae for both 

proposed and current staff. Does the 

applicant plan to coordinate 

activities with any other injury 

surveillance, prevention, and 

control programs or activities in the 

applicant’s organizations? 

• Goals and Objectives: (10 points) 

»Are the objectives specific, 

achievable, practical, measurable, 

time-linked, and consistent with the 

overall purposes described in this 

announcement? 

• Evaluation: (10 points) 

» Did the applicant include plans to 

evaluate the attainment of proposed 

objectives, including plans to 

evaluate the sensitivity and 

predictive value positive of case 

ascertainment and the completeness 

and quality of data? 

• Review of Literature and Statement of 

Need: (5 points) 

» Did the applicant review key 

literature relevant to the proposed 

project, and did the applicant 

describe needs within the 

jurisdiction to which the 

application is responsive? 

• Budget and Justification: (not scored) 

» Are the budget reasonable, clearly 

justified, and consistent with stated 

objectives and proposed activities? 

» Has the applicant provided a 

budget to include funds for 

attending the annual grantees 

meeting? 

Part C (TBIED) 

Each application will be evaluated 

and scored individually by an objective 

review panel. All applications will be 

evaluated and scored first for Part A and 

subsequently, where applicable, for Part 

C. 

Evaluations and scoring for Part C 

will be conducted according to the 

following criteria: 

• Methods and Activities: (35 points) 

» Can the methods and activities 

achieve the proposed objectives, 

consistent with the purposes of this 

announcement? Did the applicant 

propose appropriate methods and 

activities to collect and analyze 

emergency department TBI data 

consistent with the Program 

Requirements for Part C, including 

sampling methods and proposed 

staffing? 

• Capacity to conduct TBIED 

surveillance: (20 points) 

» Did the applicant demonstrate 

authority to collect and maintain 

necessary TBI emergency 

department surveillance data 

consistent with the current CDC 

Central Nervous System Injury 

Surveillance Data Submission 

Standards, with demonstrated 

timeliness of case ascertainment, 

completeness of case ascertainment, 

and ability to analyze data? Did the 

applicant demonstrate appropriate 

existing capacity to collect and 

analyze abstracted data (e.g., 

describing TBI ED severity, 

circumstances, and early outcome) 

from a representative sample of 

cases reported to the TBI ED 

surveillance system? 

• Management and Staffing: (20 points) 

» Does the staffing plan indicate the 

applicant’s ability to carry out the 

objectives of the program? 

Considerations include: 

organizational structure, staff 

qualifications, experience, degree of 

stability maintaining current staff in 

critical positions, identified training 

needs or plan, and job descriptions 

and curricula vitae for both 

proposed and current staff. Does the 

applicant plan to coordinate 

activities with any other injury 

surveillance, prevention, and 

control programs or activities in the 

applicant’s organizations? 

• Goals and Objectives: (10 points) 

» Are the objectives specific, 

achievable, practical, measurable, 

time-linked, and consistent with the 

overall purposes described in this 

announcement? 

• Evaluation: (10 points) 

» Did the applicant include plans to 

evaluate the attainment of proposed 

objectives, including plans to 

evaluate the sensitivity and 

predictive value positive of case 

ascertainment and the completeness 

and quality of data? 

• Review of Literature and Statement of 

Need: (5 points) 

» Did the applicant review key 

literature relevant to the proposed 

project, and did the applicant 

describe needs within the 

jurisdiction to which the 

application is responsive? 

• Budget and Justification: (not scored)

Æ Are the budget reasonable, clearly 

justified, and consistent with stated 

objectives and proposed activities? 

Æ Has the applicant provided a 

budget to include funds for 

attending the annual grantees 

meeting? 

Part D (TBISL) 

Each application will be evaluated 

and scored individually by an objective 

review panel. All applications will be 

evaluated and scored first for Part A and

Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 64777

subsequently, where applicable, for Part 

D. 

Evaluations and scoring for Part D 

will be conducted according to the 

following criteria:

• Methods and Activities: (25 points) 

Æ Can the methods and activities 

achieve the proposed objectives, 

consistent with the program 

requirements for Part D of this 

announcement? 

• Capacity to link individuals with TBI 

to information about services: (20 

points) 

Æ If direct patient contact is 

proposed, did the applicant 

demonstrate authority to collect and 

maintain necessary TBI surveillance 

data? Did the applicant demonstrate 

legislative authority to contact 

individuals identified through TBI 

surveillance with information about 

services? 

• Collaboration (20 points) 

Æ Has the applicant provided 

adequate information to assist the 

relationships between the program 

and other organizations, agencies, 

and health department units that 

will be involved in TBI linkage 

activities? 

Æ Has the applicant provided a clear 

and adequate description of 

appropriate partners and their 

stated roles? 

• Management and Staffing: (10 points) 

Æ Does the staffing plan indicate the 

applicant’s ability to carry out the 

objectives of the program? 

Considerations include: 

Organizational structure, staff 

qualifications, experience, degree of 

stability maintaining current staff in 

critical positions, identified training 

needs or plan, and job descriptions 

and curricula vitae for both 

proposed and current staff. Does the 

applicant plan to coordinate 

activities with any other injury 

surveillance, prevention, and 

control programs or activities in the 

applicant’s organizations? 

• Goals and Objectives: (10 points) 

Æ Are the objectives specific, 

achievable, practical, measurable, 

time-linked, and consistent with the 

overall purposes described in this 

announcement? 

• Evaluation: (10 points) 

Æ Did the applicant include plans to 

evaluate the attainment of proposed 

objectives? 

• Review of Literature and Statement of 

Need: (5 points) 

Æ Did the applicant review key 

literature relevant to the proposed 

project, and did the applicant 

describe needs within the 

jurisdiction to which the 

application is responsive? 

• Budget and Justification: (not scored) 

Æ Are the budget reasonable, clearly 

justified, and consistent with stated 

objectives and proposed activities? 

Æ Has the applicant provided a 

budget to include funds for 

attending the annual grantees 

meeting? 

V.2. Review and Selection Process 

Applications will be reviewed for 

completeness by the Procurement and 

Grants Office (PGO) staff, and for 

responsiveness by the National Center 

for Injury Prevention and Control. 

Incomplete applications and 

applications that are non-responsive to 

the eligibility criteria will not advance 

through the review process. Applicants 

will be notified by the National Center 

for Injury Prevention and Control in 

writing that their application did not 

meet submission requirements prior to 

the start date of the award. 

An objective review panel will 

evaluate complete and responsive 

applications according to the criteria 

listed in the ‘‘V.1. Criteria’’ section 

above. Applications will be funded in 

order by score and rank determined by 

the review panel. 

VI. Award Administration Information 

VI.1. Award Notices 

Successful applicants will be notified 

by telephone of selection for funding 

and to discuss proposed budget and 

receive a Notice of Grant Award (NGA) 

from the CDC Procurement and Grants 

Office. The NGA shall be the only 

binding, authorizing document between 

the recipient and CDC. The NGA will be 

signed by an authorized Grants 

Management Officer and mailed to the 

recipient fiscal officer identified in the 

application.

VI.2. Administrative and National 

Policy Requirements 

45 CFR Part 74 and Part 92

For more information on the Code of 

Federal Regulations, see the National 

Archives and Records Administration at 

the following Internet address: http://

www.access.gpo.gov/nara/cfr/cfr-tablesearch.html.

The following additional 

requirements apply to this project:

• AR–7 Executive Order 12372

• AR–9 Paperwork Reduction Act 

Requirements 

• AR–10 Smoke-Free Workplace 

Requirements 

• AR–11 Healthy People 2010

• AR–12 Lobbying Restrictions 

• AR–13 Prohibition on Use of CDC 

Funds for Certain Gun Control 

Activities 

Additional information on these 

requirements can be found on the CDC 

web site at the following Internet 

address: http://www.cdc.gov/od/pgo/

funding/ARs.htm.

VI.3. Reporting Requirements 

You must provide CDC with an 

original, plus two hard copies of the 

following reports: 

1. Interim progress report. The 

progress report will serve as your noncompeting continuation application, 

and must contain the following 

elements: 

a. Current Budget Period Activities 

Objectives. 

b. Current Budget Period Financial 

Progress. 

c. New Budget Period Program 

Proposed Activity Objectives. 

d. Budget. 

e. Measures of Effectiveness. 

f. Additional Requested Information. 

2. Financial status report and annual 

progress report (see Appendix II for 

reporting requirements table), no more 

than 90 days after the end of the budget 

period. 

3. Final financial and performance 

reports, no more than 90 days after the 

end of the project period. 

These reports must be mailed to the 

Grants Management or Contract 

Specialist listed in the ‘‘Agency 

Contacts’’ section of this announcement. 

VI.4. Other Requirements 

Projects that involve the collection of 

information from 10 or more individuals 

and funded by cooperative agreement 

will be subject to review and approval 

by the Office of Management and 

Budget (OMB) under the Paperwork 

Reduction Act. OMB clearance for the 

data collection initiated under this 

cooperative program is pending 

approval by OMB. 

VII. Agency Contacts 

We encourage inquiries concerning 

this announcement. For general 

questions, contact: Technical 

Information Management Section, CDC 

Procurement and Grants Office, 2920 

Brandywine Road, Atlanta, GA 30341. 

Telephone: (770) 488–2700. 

For program technical assistance, 

contact: Angela Marr, Project Officer, 

4770 Buford Hwy., NE., M.S. F–41, 

Atlanta, GA 30341–3724. Tel: (770) 

488–1428. E-mail: amarr@cdc.gov.

CDC will host a program technical 

assistance conference call for this 

announcement on November 16, 2004, 

from 1 p.m. (e.s.t.) to 2 p.m. (e.s.t.). The

64778 Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 

conference bridge number is (877) 368–

9836 and the participant pass code is 

852136. For financial, grants 

management, or budget assistance, 

contact: Angie Tuttle, Grants 

Management Specialist, CDC 

Procurement and Grants Office, 2920 

Brandywine Road, Atlanta, GA 30341. 

Telephone: (770) 488–2719. E-mail: 

AEN4@cdc.gov.

VIII. Other Information 

This and other CDC funding 

opportunity announcements can be 

found on the CDC Web site, Internet 

address: www.cdc.gov. Click on 

‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements.’’

Dated: November 2, 2004. 

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–24809 Filed 11–5–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

Advisory Committee; Renewals

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

renewal of certain FDA advisory 

committees by the Commissioner of 

Food and Drugs (the Commissioner). 

The Commissioner has determined that 

it is in the public interest to renew the 

charters of the committees listed in table 

1 of this document for an additional 2 

years beyond charter expiration date. 

The new charters will be in effect until 

the dates of expiration listed in table 1. 

This notice is issued under the Federal 

Advisory Committee Act of October 6, 

1972 (Public Law 92–463 (5 U.S.C. app. 

2)).

DATES: Authority for these committees 

will expire on the dates indicated in 

table 1 of this document unless the 

Commissioner formally determines that 

renewal is in the public interest.

TABLE 1.

Name of committee Date of expiration 

Anesthetic and Life Support Drugs Advisory Committee ......................................................................................................... May 1, 2006.

Blood Products Advisory Committee ........................................................................................................................................ May 13, 2006.

Pulmonary-Allergy Drugs Advisory Committee ......................................................................................................................... May 30, 2006.

Drug Safety and Risk Management Advisory Committee ........................................................................................................ May 31, 2006.

Science Advisory Board to the National Center for Toxicological Research ........................................................................... June 2, 2006.

Peripheral and Central Nervous System Drugs Advisory Committee ...................................................................................... June 4, 2006.

Psychopharmacologic Drugs Advisory Committee ................................................................................................................... June 4, 2006.

Transmissible Spongiform Encephalopathies Advisory Committee ......................................................................................... June 9, 2006.

Science Board to the Food and Drug Administration ............................................................................................................... June 26, 2006.

Allergenic Products Advisory Committee .................................................................................................................................. July 9, 2006.

Cardiovascular and Renal Drugs Advisory Committee ............................................................................................................ August 27, 2006.

Endocrinologic and Metabolic Drugs Advisory Committee ....................................................................................................... August 27, 2006.

Oncologic Drugs Advisory Committee ...................................................................................................................................... September 1, 2006.

Anti-Infective Drugs Advisory Committee ................................................................................................................................. October 7, 2006.

Dermatologic and Ophthalmic Drugs Advisory Committee ...................................................................................................... October 7, 2006.

Cellular, Tissue, and Gene Therapies Advisory Committee (formerly Biological Response Modifiers Advisory Committee) October 28, 2006.

FOR FURTHER INFORMATION CONTACT:

Linda A. Sherman, Advisory Committee 

Oversight and Management Staff (HF–

4), Food and Drug Administration, 5600 

Fishers Lane, Rockville, MD 20857, 

301–827–1220.

Dated: October 29, 2004.

Sheila Dearybury Walcoff,

Associate Commissioner for External 

Relations.

[FR Doc. 04–24842 Filed 11–5–04; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Center for 

Research Resources Special Emphasis Panel 

Clinical Research. 

Date: November 17–18, 2004. 

Time: November 17, 2004, 8 a.m. to 

Adjournment. 

Agenda: To review and evaluate grant 

applications. 

Place: Omni Charlottesville Hotel, 235 

West Main Street, Charlottesville, VA 22902. 

Contact Person: Carol Lambert, PhD, 

Scientific Review Administrator, Office of 

Review, National Institutes of Health, NCRR, 

6701 Democracy Blvd., 1 Democracy Plaza, 

Room 1076, MSC 4874, Bethesda, MD 20892, 

(301) 435–0814, lambert@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333, National Institutes of Health, 

HHS.)

Dated: October 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–24795 Filed 11–5–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as